Novel immunotherapeutic approaches for hepatocellular carcinoma treatment

scientific article published on 14 April 2019

Novel immunotherapeutic approaches for hepatocellular carcinoma treatment is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1080/17512433.2019.1598859
P698PubMed publication ID30907177

P50authorMichele Dal BoQ42703041
Giuseppe ToffoliQ54252459
P2093author name stringLorena Baboci
Federica Di Cintio
Davide Busato
Monica Mossenta
P2860cites workInduced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell deathQ24293504
P433issue5
P921main subjecthepatocellular carcinomaQ1148337
P304page(s)453-470
P577publication date2019-04-14
P1433published inExpert Review of Clinical PharmacologyQ15793519
P1476titleNovel immunotherapeutic approaches for hepatocellular carcinoma treatment
P478volume12

Reverse relations

cites work (P2860)
Q91230219A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer
Q92977405Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities
Q102141646Immunopathobiology and therapeutic targets related to cytokines in liver diseases
Q92344153New Insight into Therapies Targeting Angiogenesis in Hepatocellular Carcinoma
Q90749815Platelets and Hepatocellular Cancer: Bridging the Bench to the Clinics